Type 2 diabetes is a chronic metabolic condition that affects millions of people worldwide. Characterized by high blood sugar levels, insulin resistance, and progressive pancreatic dysfunction, it requires long-term management to prevent serious complications. In recent years, GLP-1 receptor agonists have emerged as a breakthrough in diabetes care. One such advanced option is the Semanize...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek